Boston Scientific Future Growth
Future criteria checks 3/6
Boston Scientific is forecast to grow earnings and revenue by 18.2% and 8.8% per annum respectively. EPS is expected to grow by 17.8% per annum. Return on equity is forecast to be 16.8% in 3 years.
Key information
18.2%
Earnings growth rate
17.8%
EPS growth rate
Medical Equipment earnings growth | 21.5% |
Revenue growth rate | 8.8% |
Future return on equity | 16.8% |
Analyst coverage | Good |
Last updated | 26 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 19,197 | 3,218 | 3,649 | N/A | 24 |
12/31/2025 | 17,521 | 2,693 | 2,943 | N/A | 30 |
12/31/2024 | 15,989 | 2,145 | 2,234 | N/A | 27 |
3/31/2024 | 14,707 | 1,765 | N/A | N/A | N/A |
12/31/2023 | 14,240 | 1,570 | 1,822 | 2,503 | N/A |
9/30/2023 | 13,757 | 1,191 | 1,736 | 2,353 | N/A |
6/30/2023 | 13,400 | 861 | 1,559 | 2,125 | N/A |
3/31/2023 | 13,045 | 846 | 1,256 | 1,774 | N/A |
12/31/2022 | 12,682 | 642 | 1,008 | 1,526 | N/A |
9/30/2022 | 12,567 | 596 | 629 | 1,197 | N/A |
6/30/2022 | 12,329 | 828 | 668 | 1,192 | N/A |
3/31/2022 | 12,162 | 754 | 1,007 | 1,528 | N/A |
12/31/2021 | 11,888 | 985 | 1,398 | 1,870 | N/A |
9/30/2021 | 11,470 | 1,101 | 1,701 | 2,065 | N/A |
6/30/2021 | 11,196 | 526 | 1,939 | 2,243 | N/A |
3/31/2021 | 10,122 | 201 | 1,604 | 1,869 | N/A |
12/31/2020 | 9,913 | -115 | 1,219 | 1,508 | N/A |
9/30/2020 | 10,108 | 3,685 | 1,242 | 1,527 | N/A |
6/30/2020 | 10,157 | 3,980 | 1,008 | 1,386 | N/A |
3/31/2020 | 10,785 | 4,287 | 986 | 1,409 | N/A |
12/31/2019 | 10,735 | 4,700 | 1,427 | 1,836 | N/A |
9/30/2019 | 10,392 | 1,090 | 782 | 1,163 | N/A |
6/30/2019 | 10,077 | 1,396 | 826 | 1,162 | N/A |
3/31/2019 | 9,937 | 1,797 | 148 | 467 | N/A |
12/31/2018 | 9,823 | 1,671 | -6 | 310 | N/A |
9/30/2018 | 9,670 | 670 | 686 | 975 | N/A |
6/30/2018 | 9,500 | 521 | 653 | 926 | N/A |
3/31/2018 | 9,267 | 112 | 1,359 | 1,626 | N/A |
12/31/2017 | 9,048 | 104 | N/A | 1,426 | N/A |
9/30/2017 | 8,831 | 843 | N/A | 1,418 | N/A |
6/30/2017 | 8,714 | 788 | N/A | 935 | N/A |
3/31/2017 | 8,582 | 435 | N/A | 1,059 | N/A |
12/31/2016 | 8,386 | 347 | N/A | 1,182 | N/A |
9/30/2016 | 8,095 | 81 | N/A | 835 | N/A |
6/30/2016 | 7,878 | -345 | N/A | 1,274 | N/A |
3/31/2016 | 7,595 | -36 | N/A | 913 | N/A |
12/31/2015 | 7,477 | -239 | N/A | 691 | N/A |
9/30/2015 | 7,314 | -396 | N/A | 711 | N/A |
6/30/2015 | 7,272 | -155 | N/A | 649 | N/A |
3/31/2015 | 7,302 | -253 | N/A | 874 | N/A |
12/31/2014 | 7,308 | -119 | N/A | 1,269 | N/A |
9/30/2014 | 7,258 | 288 | N/A | 1,104 | N/A |
6/30/2014 | 7,147 | 240 | N/A | 1,009 | N/A |
3/31/2014 | 7,083 | 366 | N/A | 1,121 | N/A |
12/31/2013 | 7,070 | -121 | N/A | 1,110 | N/A |
9/30/2013 | 7,126 | -168 | N/A | 1,204 | N/A |
6/30/2013 | 7,125 | -827 | N/A | 1,225 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0HOY's forecast earnings growth (18.2% per year) is above the savings rate (1.8%).
Earnings vs Market: 0HOY's earnings (18.2% per year) are forecast to grow faster than the UK market (12.4% per year).
High Growth Earnings: 0HOY's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0HOY's revenue (8.8% per year) is forecast to grow faster than the UK market (3.4% per year).
High Growth Revenue: 0HOY's revenue (8.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0HOY's Return on Equity is forecast to be low in 3 years time (16.8%).